Abstract
The bis(4′-(4-tolyl)-2,2′:6′,2″-terpyridine)copper(II) complex [Cu(ttpy)2]Cl2 was synthesized and authenticated by single crystal analysis, which shows distorted octahedral geometry around copper(II) ion. The crystal packing is stabilized by C–H···π inter and intramolecular interactions. The complex was found to be lipophilic as determined by shake-flask method. In vitro cytotoxicity of the complex was tested against Ehrlich ascites carcinoma (EAC) and L6 myotube cell lines. The complex exhibit potent cytotoxicity with respect to the commercially available anticancer drug cisplatin. Hoechst 33258, AO/EB and PI (flow cytometry) staining methods suggest that the complex can induce apoptosis in EAC cells. Cell cycle analyses also support the induced apoptosis. Cellular uptake studies revealed that the complex can go into the cytoplasm and accumulate in the cell nuclei. The complex induces EAC cell apoptosis through a ROS-mediated mitochondrial pathway by activating caspase 3 and caspase 7 and regulates the Bcl-2 family proteins. In vivo study of the complex was validated against the animal tumor growth (EAC) cell in Swiss albino mice.
Graphical abstract
The bis(4′-(4-tolyl)-2,2′:6′,2″-terpyridine)copper(II) complex induces EAC cell apoptosis through a ROS-mediated mitochondrial pathway and significantly reduced the body weight and solid tumor volume in Swiss albino mice.
We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.
References
Monneret C (2011) Ann Pharm Fr 69:286–295
Galluzzi L, Vitale I, Michels J, Brenner C, Szabadkai G, Harel-Bellan A, Castedo M, Kroemer G (2014) Cell Death Dis 5:e1257
Bruijnincx PCA, Sadler PJ (2008) Curr Opin Chem Biol 12:197–206
Jung Y, Lippard SJ (2007) Chem Rev 107:1387–1407
Griffith D, Parker JP, Marmion CJ (2010) Anti Cancer Agents Med Chem 10:354–370
Linder MC (1991) Biochemistry of copper. Plenum, New York
Hassouneh B, Islam M, Nagel T, Pan Q, Merajver SD, Teknos TN (2007) Mol Cancer Ther 6:1039–1045
Xie H, Kang YJ (2009) Curr Med Chem 16:1304–1314
Eatock MM, Schatzlein A, Kaye SB (2000) Cancer Treat Rev 26:191–204
Brewer GJ (2001) Exp Biol Med 226:665–673
Engleka KA, Maciag T (1994) J Biol Chem 267:11307–11315
Shing Y (1998) J Biol Chem 263:9059–9062
Hu GF (1998) J Cell Biochem 69:326–335
Winder AJ, Harris H (1991) Eur J Biochem 198:317–326
Jinxu Q, Shichu L, Yi G, Zhenlei Z, Zuping Z, Feng Y, Hong L (2015) Eur J Med Chem 96:360–368
Prosser KE, Chang SW, Saraci F, Lě PH, Walsby CJ (2017) J Inorg Biochem 167:89–99
Palanimuthu D, Shinde S, Somasundaram K, Samuelson AG (2013) J Med Chem 56:722–734
Majouga AG, Zvereva MI, Rubtsova MP, Skvortsov DA, Mironov AV, Azhibek DM, Krasnovskaya OO, Gerasimov VM, Udina AV, Vorozhtsov NI, Beloglazkina EK, Agron L, Mikhina LV, Tretyakova AV, Zyk NV, Zefirov NS, Kabanov AV, Dontsova OA (2014) J Med Chem 57:6252–6258
Akladios FN, Andrew SD, Parkinson CJ (2016) J Biol Inorg Chem 21:931–944
Kumar A, Chinta JP, Ajay AK, Bhat MK, Rao CP (2011) Dalton Trans 40:10865–10872
Mendo AS, Figueiredo S, Roma-Rodrigues C, Videira PA, Ma Z, Diniz M, Larguinho M, Costa PM, Lima JC, Pombeiro AJL, Baptista PV, Fernandes AR (2015) J Biol Inorg Chem 20:935–948
Mahendiran D, Kumar RS, Viswanathan V, Velmurugan D, Rahiman AK (2016) Dalton Trans 45:7794–7814
Deka B, Sarkar T, Banerjee S, Kumar A, Mukherjee S, Deka S, Saikia KK, Hussain A (2017) Dalton Trans 46:396–409
Manikandamathavan VM, Thangaraj M, Weyhermüller T, Parameswari RP, Punitha V, Murthy NN, Nair BU (2017) Eur J Med Chem 135:434–446
Santini C, Pellei M, Gandin V, Porchia M, Tisato F, Marzano C (2014) Chem Rev 114:815–862
Yoshida D, Ikeda Y, Nakazawa S (1993) J Neurooncol 17:91–97
Uma V, Kanthimathi M, Weyhermüller T, Nair BU (2005) J Inorg Biochem 99:2299–2307
Roy S, Saha S, Majumdar R, Dighe RR, Chakravarty AR (2010) Polyhedron 29:3251–3256
Allen FH, Kennard O, Watson DG, Brammer L, Orpen AG, Taylor R (1987) J Chem Soc Perkin Trans 2:S1–S19
Hansch C, Leo A, Hoekman DH (1995) Exploring QSAR. Fundamentals and application in chemistry and biology. American Chemical Society, Washington, DC
Varbanov HP, Valiahdi SM, Kowol CR, Jakupec MA, Galanski M, Keppler BK (2012) Dalton Trans 41:14404–14415
Mazuryk O, Magiera K, Rys B, Suzenet F, Kieda C, Brindell M (2014) J Biol Inorg Chem 19:1305–1316
Liu JJ, Galettis P, Farr A, Maharaj L, Samarasinha H, McGechan AC, Baguley BC, Bowen RJ, Berners-Price SJ, McKeage MJ (2008) J Inorg Biochem 102:303–310
Danielsson L-G, Zhang Y-H (1996) Trends Anal Chem 15:188–196
Raman N, Pravin N (2014) Eur J Med Chem 80:57–70
Pan MH, Chang YH, Badmave V, Nagabhushanam K, Ho CT (2007) J Agric Food Chem 55:7777–7785
Kawiak A, Zawacka-Pankau J, Wasilewska A, Stasilojc G, Bigda J, Lojkowska E (2012) J Nat Prod 75:9–14
Su CC, Lin JG, Li TM, Chung JG, Yang JS, Ip SW, Lin WC, Chen GW (2006) Anticancer Res 26:4379–4389
Watson JL, Hill R, Yaffe PB, Greenshields A, Walsh M, Lee PW, Giacomantonio CA, Hoskin DW (2010) Cancer Lett 297:1–8
Sullivan LB, Chandel NS (2014) Cancer Metab 2:17–28
Li LL, Wong YS, Chen TF, Fan CD, Zheng WJ (2012) Dalton Trans 41:1138–1141
Yap A, Nishiumi S, Yoshida K, Ashida H (2007) Cytotechnology 55:103–108
Weintraub S, Moskovitz Y, Fleker O, Levy AR, Meir A, Ruthstein S, Benisvy L, Gruzman A (2015) J Biol Inorg Chem 20:1287–1298
Mahendiran D, Gurumoorthy P, Gunasekaran K, Kumar RS, Rahiman AK (2015) New J Chem 39:7895–7911
Mahendiran D, Kumar RS, Rahiman AK (2017) Mater Sci Eng C 76:601–615
Liu Y-J, Liang Z-H, Hong X-L, Li Z-Z, Yao J-H, Huang H-L (2012) Inorg Chim Acta 387:117–124
Organization for Economic Co-operation and Development (2001) OECD guidelines for testing of chemical, Acute oral toxicity-Acute toxic class method, vol 423. Paris, pp 1–14
Gupta M, Mazumder UK, Kumar RS, Sivakumar T, Vamsi MLM (2004) J Pharmcol Sci 94:177–184
Kumar RS, Rajkapoor B, Perumal P (2011) Asian Pac J Trop Med 4:379–385
Kumar RS, Rajkapoor B, Perumal P (2011) Asian Pac J Cancer Prev 12:613–618
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
About this article
Cite this article
Mahendiran, D., Kumar, R.S., Viswanathan, V. et al. In vitro and in vivo anti-proliferative evaluation of bis(4′-(4-tolyl)-2,2′:6′,2″-terpyridine)copper(II) complex against Ehrlich ascites carcinoma tumors. J Biol Inorg Chem 22, 1109–1122 (2017). https://doi.org/10.1007/s00775-017-1488-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-017-1488-6